2024 annual financial data
Ionis Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was -67.37%.
Operating income was -475,081,000 USD and net income was -453,897,000 USD.
Operating cash flow was -500,947,000 USD.
Get free Ionis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 705,138,000 USD
- Operating income
- -475,081,000 USD
- Net income
- -453,897,000 USD
- Operating cash flow
- -500,947,000 USD